Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and Caregiver

NCT00272727 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2011-01-24

No results posted yet for this study

Summary

The purpose of the study is to assess if a dialog tool can improve compliance and asthma control in patients with asthma.

Conditions

Interventions

BEHAVIORAL

Dialog tool for caregivers

Sponsors & Collaborators

Principal Investigators

  • AstraZeneca Denmark Medical Director, MD · AstraZeneca

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Completion
2007-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00272727 on ClinicalTrials.gov